John T. Curnutte
CIK: 0001574589
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PLRX
PLIANT THERAPEUTICS, INC.
Director
Discretionary Trading P&L
Holdings
About Curnutte John T
Curnutte John T (SEC CIK 0001574589) files insider reports with the SEC as Director of PLIANT THERAPEUTICS, INC. (PLRX).
Signal8 holds 2 ownership filings by Curnutte John T, all Form 4s, filed between Jun 9, 2025 and Jun 12, 2026. Those filings report 2 transactions, from Jun 5, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Curnutte John T's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Curnutte John T
Other insiders filing for PLIANT THERAPEUTICS, INC. (PLRX)
- Raben David, Chief Medical Officer
- Iannone Robert, Director
- Borellini Flavia, Director
- CROWELL GAYLE A, Director
- MCCOURT Thomas A, Director
- Krognes Steve E., Director